Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
11
|
| pubmed:dateCreated |
1991-12-13
|
| pubmed:abstractText |
High frequencies of CD5+TcR alpha/beta- T cells were induced in the peritoneal cavity of rats immunized with syngeneic W439 lymphoma cells. These TcR alpha/beta- cells expressed TcR delta mRNA as analyzed by the polymerase chain reaction technique. The delta + (TcR gamma/delta +) T cells were of the CD2+, CD3+, CD4-, CD8+, CD45RB+ phenotype and showed stronger anti-tumor cytotoxicity compared to the TcR alpha/beta + T cells. The cytotoxic effects of both alpha/beta and gamma/delta T cells were selective for the W439 lymphoma cells and were not directed to other syngeneic tumors, natural killer targets and syngeneic or allogeneic normal cells. T cells, including both alpha/beta and gamma/delta cells, were induced when WF rats were immunized with allogeneic BN spleen cells. In this case the gamma/delta T cells showed allo-selective cytotoxicity, although weaker compared to the TcR alpha/beta + T cells. The gamma/delta T cells, induced by immunization with either W439 cells or BN spleen cells, were selective for the immunogen used and had no effect on irrelevant target cells, indicating that these effector cells were not activated by a shared gamma/delta T cell-related superantigen. Since highly potent tumor-selective gamma/delta cytotoxic T lymphocytes could be induced by syngeneic lymphoma cells, we suggest a role for gamma/delta T cells in the defense against certain types of tumors.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
0014-2980
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
21
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2797-802
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:1718760-Animals,
pubmed-meshheading:1718760-Antigens, CD,
pubmed-meshheading:1718760-Antigens, CD5,
pubmed-meshheading:1718760-Ascitic Fluid,
pubmed-meshheading:1718760-Base Sequence,
pubmed-meshheading:1718760-Cytotoxicity, Immunologic,
pubmed-meshheading:1718760-Flow Cytometry,
pubmed-meshheading:1718760-Gene Expression,
pubmed-meshheading:1718760-Molecular Sequence Data,
pubmed-meshheading:1718760-Neoplasms, Experimental,
pubmed-meshheading:1718760-Polymerase Chain Reaction,
pubmed-meshheading:1718760-Rats,
pubmed-meshheading:1718760-Rats, Inbred BN,
pubmed-meshheading:1718760-Rats, Inbred WF,
pubmed-meshheading:1718760-Receptors, Antigen, T-Cell, alpha-beta,
pubmed-meshheading:1718760-Receptors, Antigen, T-Cell, gamma-delta,
pubmed-meshheading:1718760-T-Lymphocyte Subsets,
pubmed-meshheading:1718760-T-Lymphocytes, Cytotoxic
|
| pubmed:year |
1991
|
| pubmed:articleTitle |
In vivo induction of gamma/delta T cells with highly potent and selective anti-tumor cytotoxicity.
|
| pubmed:affiliation |
Wallenberg Laboratory, Department of Tumor Immunology, University of Lund, Sweden.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|